Oximio (Formerly SMO Group)

Oximio (Formerly SMO Group) excels in delivering comprehensive clinical trial services, contributing significantly to global medical research and the development of effective treatments. With over 19 years of experience, Oximio is dedicated to transforming investigational medical products into innovative medicines, serving a diverse clientele from startups to major international pharmaceutical and R&D organizations.

Strategically located at GIBSON HOUSE ERMINE BUSINESS PARK, Huntingdon, Cambridgeshire, PE29 6XU, GB, Oximio provides a direct connection to extensive patient communities across the United Kingdom, Eastern Europe, Western Asia, and South Africa. Oximio's capabilities include meticulous supply planning, comparator sourcing, patient-centric solutions, advanced therapy support, expert handling of import & export regulations, relabeling, secure warehousing, efficient distribution and courier services, and compliant returns & destruction processes. Oximio also has locations in Bareket Street, Industrial Park North P.O. Box 3187, Caesarea, 3079863, IL; Smolna str., Kiev, Kiev 03022, UA; and Ksani Street, Tbilisi, Tbilisi 0141, GE; Zapadnaya Street 22, Odintsovo, Moscow region, RU; Tópark utca 1, Törökbálint, Pest 2045, HU; I.A.O.S.B. 10053 Sok. No: 7/1, Izmir, TR; Bulevard Kralja Aleksandra 28, Belgrade, RS; 22 Venturi Crescent, Hennopspark, Centurion, 0157 , ZA.

Leveraging a ‘best-in-class’ depot network and a highly skilled workforce, Oximio is adept in both global and local clinical trial procedures, ensuring the highest operational standards. The company is committed to maintaining end-to-end cold-chain control across all its facilities. We invite the management team at Oximio to further enrich this profile with a customized company showcase and detailed product listings on our platform.